VTI1B Human

Vesicle Transport Through Interaction with t-SNAREs Homolog 1B Human Recombinant
Shipped with Ice Packs
In Stock

Description

Basic Information of VTI1B

PropertyDetails
Protein NameVesicle transport through interaction with t-SNAREs homolog 1B
Gene NameVTI1B
UniProt IDQ9UEU0
OrganismHomo sapiens (Human)
Amino Acid Length232
Transmembrane Domains1
Key DomainsQb-SNARE motif
Sequence MotifMASSAASSEHFEKLHE... (truncated; full sequence available in UniProt)

This protein localizes to the Golgi complex, endosomes, lysosomes, and secretory vesicles .

Molecular Functions and Pathways

VTI1B facilitates membrane fusion events through SNARE complex formation:

  • Autophagy: Partners with syntaxin 7 (STX7), syntaxin 8 (STX8), and VAMP7 to mediate fusion between recycling endosomes and autophagosomes .

  • Immune Synapse (IS) Dynamics: Recruited to B cell receptor (BCR) activation sites and polarizes to IS interfaces during antigen presentation .

  • Cytokine Secretion: Essential for post-Golgi trafficking of cytokines in macrophages and secretory lysosome release in cytotoxic lymphocytes .

Localization and Trafficking Roles

  • Resting B Cells: Predominantly associates with Golgi, Rab5⁺ (early endosomes), Rab7⁺ (late endosomes/lysosomes), and Rab11⁺ (recycling endosomes) .

  • BCR Activation: Enriches at antigen internalization sites and perinuclear compartments within 5–60 minutes of activation .

  • Immune Synapse: Colocalizes with lysosomes and F-actin foci, suggesting roles in antigen extraction or vesicle recycling .

Key Studies Using VTI1B-Knockout (KO) Mice:

  • BCR Signaling: No significant defects in BCR internalization, PLCγ2 phosphorylation, or ERK/AKT signaling pathways .

  • Antigen Processing: Partial colocalization with internalized antigen vesicles but no impairment in antigen presentation efficiency .

  • Functional Redundancy: Lack of phenotypic changes in KO models implies compensatory mechanisms by other SNAREs (e.g., VTI1A) .

Regulatory and Environmental Interactions

VTI1B expression is modulated by:

ModulatorEffect on VTI1BSource Model
Bisphenol S/F↑ mRNA/protein expressionHuman/Rat studies
Cyclosporin A↓ mRNA expressionHuman cell lines
Heroin↓ mRNA expressionHuman neurons
Omega-6 fatty acids↑ mRNA expressionHuman macrophages

These findings highlight its sensitivity to endocrine disruptors and metabolic signals .

Interaction Partners and Complexes

VTI1B forms functional SNARE complexes with:

  • Syntaxin 8 (STX8): Critical for late endosomal trafficking .

  • Syntaxin 7 (STX7): Mediates autophagosome-endosome fusion .

  • VAMP7/VAMP8: Facilitates lysosomal exocytosis in immune cells .

Implications in Disease and Therapeutics

While direct disease associations remain understudied, VTI1B’s role in autophagy and cytokine secretion suggests potential relevance in:

  • Autoimmune Disorders: Dysregulated vesicle trafficking in B cells.

  • Cancer: Altered secretory pathways in tumor-associated macrophages.

  • Neurodegeneration: SNARE dysfunction in neuronal vesicle transport .

Product Specs

Introduction
VTI1B, a v-SNARE protein, plays a crucial role in vesicle transport by interacting with t-SNAREs on target membranes. These interactions ensure specificity in vesicle trafficking and promote fusion between lipid bilayers. VTI1B is believed to be involved in the elevated secretion of cytokines associated with cellular senescence.
Description
Recombinant human VTI1B, expressed in E. coli, is a single, non-glycosylated polypeptide chain consisting of 231 amino acids (residues 1-208) with a molecular weight of 26.3 kDa. Note that the molecular weight observed on SDS-PAGE may be higher. The protein features a 23 amino acid His-tag at the N-terminus and is purified using proprietary chromatographic techniques.
Physical Appearance
Clear, sterile-filtered solution.
Formulation
The VTI1B protein solution is provided at a concentration of 0.25 mg/ml in a buffer containing 20 mM Tris-HCl (pH 8.0), 30% glycerol, 0.15 M NaCl, and 1 mM DTT.
Stability
For short-term storage (2-4 weeks), the protein can be stored at 4°C. For extended storage, freezing at -20°C is recommended. To further enhance stability during long-term storage, consider adding a carrier protein like 0.1% HSA or BSA. Repeated freezing and thawing cycles should be avoided.
Purity
The purity of the protein is greater than 85% as determined by SDS-PAGE analysis.
Synonyms
Vesicle transport through interaction with t-SNAREs homolog 1B, Vesicle transport v-SNARE protein Vti1-like 1, Vti1-rp1, VTI1B, VTI1, VTI1L, VTI1L1, VTI2, v-SNARE, VTI1-LIKE.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMASSAAS SEHFEKLHEI FRGLHEDLQG VPERLLGTAG TEEKKKLIRD FDEKQQEANE TLAEMEEELR YAPLSFRNPM MSKLRNYRKD LAKLHREVRS TPLTATPGGR GDMKYGIYAV ENEHMNRLQS QRAMLLQGTE SLNRATQSIE RSHRIATETD QIGSEIIEEL GEQRDQLERT KSRLVNTSEN LSKSRKILRS MSRKVTTNKL L.

Q&A

What is VTI1B and what is its primary function in human cells?

VTI1B (Vesicle Transport through Interaction with t-SNAREs 1B) is a SNARE protein involved in vesicular trafficking in human cells. Current evidence indicates that VTI1B primarily localizes to the Golgi apparatus and a subset of Rab7+ lysosomal vesicles in resting B cells . As a SNARE protein, it likely participates in membrane fusion events necessary for intracellular transport processes, particularly within the endosomal system. In B lymphocytes, VTI1B appears to be recruited to sites of B cell receptor (BCR) activation, suggesting specific roles in immune cell function .

Where is VTI1B predominantly localized in human B cells?

Research demonstrates that VTI1B concentrates in several distinct subcellular compartments:

Cellular CompartmentVTI1B LocalizationAssociated MarkersObservation Methods
Golgi ComplexHighRab6Fluorescence microscopy
Lysosomal VesiclesPartialRab7Colocalization analysis
Cell PeripheryVariable-GFP-tagging
Immune SynapseEnriched upon activationBCR, F-actinQuantitative imaging

Research findings show GFP-fused VTI1B predominantly concentrates at the Golgi complex, around the microtubule organizing center (MTOC), as well as in Rab7+ lysosomal vesicles in the cell periphery . Upon B cell activation, partial relocalization to internalized antigen vesicles occurs, particularly in the cell periphery .

How is VTI1B recruitment regulated during immune synapse formation?

Upon BCR activation with surface-bound antigen, VTI1B demonstrates specific recruitment to the immunological synapse (IS). Experimental evidence shows:

  • GFP-VTI1B significantly polarizes to the IS upon BCR activation using antigen-coated beads or coverslips

  • Quantitative analysis confirms polarization of Golgi-associated perinuclear VTI1B compartments toward the IS

  • Mean fluorescence intensity measurements reveal significant enrichment of VTI1B signal at the bead:cell contact area compared to the distal pole

  • At the IS interface, VTI1B colocalizes with F-actin foci and Rab7+ structures, but shows limited colocalization with Rab11 and Rab6

These findings suggest VTI1B trafficking during IS formation involves cytoskeletal elements and specific endosomal compartments rather than recycling endosomes or Golgi-derived vesicles alone.

What are the potential mechanisms of functional redundancy for VTI1B in human cells?

Despite clear localization of VTI1B to sites of BCR activation and immune synapses, studies using VTI1B-deficient mouse models revealed no significant functional defects in:

  • BCR signaling pathway activation

  • Immunological synapse formation

  • Processing and presentation of internalized antigen

  • BCR surface expression levels

  • BCR internalization rates upon activation

This striking lack of phenotype suggests robust compensatory mechanisms, likely involving VTI1B's close homologue VTI1A or other SNARE proteins . This redundancy may represent an evolutionary safeguard for maintaining critical immune cell functions. Researchers investigating VTI1B function should consider:

  • Simultaneous knockdown of multiple SNARE proteins

  • Acute inhibition methods to avoid compensatory adaptations

  • Analysis of subtle phenotypes under specialized conditions

  • Identification of cell types where redundancy might be less effective

What is the relationship between VTI1B localization and antigen processing pathways?

  • BCR internalization upon activation

  • IS formation as measured by F-actin spreading area

  • BCR signaling based on phosphorylated PLCγ2 intensity

  • Early (pCD19, pSyk) and late (pAKT, pERK1/2) BCR signaling pathway components

These findings present an intriguing paradox: despite specific recruitment to antigen-containing compartments, VTI1B appears dispensable for antigen processing functions, at least in the experimental systems examined.

What are the optimal techniques for detecting and studying VTI1B in human cells?

Researchers face several technical challenges when studying endogenous VTI1B. Based on published methodologies, the following approaches have proven effective:

TechniqueApplicationAdvantagesLimitations
Antibody DetectionWestern blotCan detect endogenous proteinHigh background in immunofluorescence
GFP-VTI1B TransfectionLocalization studiesReal-time monitoring, bright signalPotential overexpression artifacts
Knockout/KnockdownFunctional analysisComplete elimination of proteinPotential compensatory mechanisms
Colocalization AnalysisCompartment identificationEstablishes subcellular locationRequires multiple validated markers
Bead/Surface ActivationImmune synapse studiesQuantifiable recruitmentIn vitro approximation of in vivo process

When designing experiments, researchers should validate antibodies using positive controls such as GFP-VTI1B transfected cells . For localization studies, comparing results from multiple detection methods is recommended.

How can researchers quantitatively assess VTI1B polarization to the immune synapse?

Published research demonstrates effective methods for quantifying VTI1B polarization during immune synapse formation:

  • Distance measurement: Calculate the distance from the VTI1B endosomal compartment to the center of the activating bead or surface

  • Polarization index: Compare mean fluorescence intensities of VTI1B between the contact site and the distal pole of the cell

  • Colocalization analysis: Measure overlap with specific markers (F-actin, BCR, Rab proteins) at the immune synapse interface

Researchers should include appropriate controls (uncoated beads or fibronectin-coated surfaces) and collect data from multiple independent experiments to ensure statistical validity .

What experimental models are most appropriate for studying VTI1B function in human immune cells?

Based on current research approaches, several experimental systems can be employed:

  • Cell lines: Human B cell lines like Raji provide a consistent system for studying endogenous VTI1B

  • Primary cells: While challenging to obtain, primary human B cells would offer the most physiologically relevant system

  • Transfection models: GFP-VTI1B transfection in appropriate cell lines allows dynamic visualization

  • Knockout models: CRISPR/Cas9 technology can generate VTI1B-deficient human cell lines

  • In vitro activation systems: Anti-IgM coated beads or coverslips effectively mimic immune synapse formation

When selecting a model system, researchers should consider the specific research question, technical feasibility, and physiological relevance of the chosen system.

How should researchers interpret the discrepancy between VTI1B localization and knockout phenotypes?

The paradoxical observation that VTI1B localizes to BCR activation sites yet appears functionally dispensable presents an interpretive challenge. When analyzing such data, researchers should consider:

  • Functional redundancy: The loss of VTI1B function may be compensated by its homologue VTI1A or other SNARE proteins

  • Condition-specific requirements: VTI1B may be essential under specific physiological conditions not captured in standard laboratory experiments

  • Subtle phenotypes: The absence of gross defects does not preclude minor functional alterations that require specialized detection methods

  • Regulatory rather than essential roles: VTI1B may optimize rather than enable specific cellular processes

  • Technical limitations: Current methodologies might not capture the true functional contribution of VTI1B

A comprehensive approach would involve simultaneous manipulation of multiple redundant components while examining a broad range of cellular functions under diverse conditions.

What methodological considerations affect interpretation of VTI1B localization data?

When interpreting VTI1B localization studies, researchers should consider several methodological factors:

  • Overexpression artifacts: GFP-VTI1B transfection may alter localization patterns compared to endogenous protein

  • Dynamic versus static analysis: Fixed-cell imaging may miss transient localization events visible in live-cell studies

  • Resolution limitations: Standard confocal microscopy may not resolve distinct membrane subdomains

  • Marker selection: Colocalization depends on the specific markers chosen (Rab6, Rab7, Rab11, etc.)

  • Activation conditions: Different modes of BCR activation (soluble vs. surface-bound antigen) may affect VTI1B dynamics

Researchers should employ complementary approaches and appropriate controls to ensure robust interpretation of localization data.

Product Science Overview

Structure and Function

VTI1B is a v-SNARE (vesicle SNARE) protein that interacts with t-SNAREs (target SNAREs) on the target membrane. These interactions are critical for the specificity of vesicle trafficking and the promotion of lipid bilayer fusion . The protein contains a C-terminal transmembrane domain and two predicted coiled-coil regions . The human VTI1B protein is composed of 232 amino acids .

Biological Role

The primary function of VTI1B is to mediate vesicle transport pathways. This involves the transport of vesicles from the Golgi apparatus to the endosomes and lysosomes . VTI1B is also implicated in the secretion of cytokines associated with cellular senescence . The protein is expressed in all human tissues, indicating its fundamental role in cellular processes .

Genetic Information

The gene encoding VTI1B is located on chromosome 14q24.1 . It has several synonyms, including VTI1, VTI1L, VTI1L1, and VTI2 . The gene is highly conserved across species, with the human protein showing 29% identity to its yeast homolog .

Clinical Significance

Mutations or dysregulation of VTI1B can have significant implications for cellular function. For instance, disruptions in VTI1B interactions can lead to improper vesicle trafficking, which may contribute to various diseases . The protein’s role in cytokine secretion also suggests a potential link to inflammatory conditions and cellular aging .

Research and Applications

Research on VTI1B has provided insights into the molecular mechanisms of vesicle transport and membrane fusion. The protein’s interactions with clathrin-coated vesicles and its role in post-Golgi trafficking are areas of active investigation . Understanding these processes can inform the development of therapeutic strategies for diseases related to vesicle transport dysfunction.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.